Bluepharma

ACIES BIO is a biotechnology contract research organization offering state-of-the-art R&D services to pharmaceutical, chemical, biotech and food industries. We provide full support from idea conceptualization through research to product development. Combining biotechnology and synthetic organic chemistry expertise, we offer a comprehensive service, covering all key development steps for efficient production of biosynthetic natural products or their semi-synthetic derivatives, as well as entirely synthetic compounds.

Working with some of the largest international companies, we provide to our clients full R&D support both in our laboratories as well as on-site at the client’s facilities.

With experience and know-how in natural product (bio)synthesis, milestone-based approach to projects, innovativeness and flexibility, as well as competitive pricing, ACIES BIO aims to become the premier partner in R&D outsourcing for pharmaceutical companies.

Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health.

Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.

At Aragen, we recognize your work is vital, urgent and impacts lives. Our purpose, ‘In every molecule is the possibility for better health’ motivates us to drive the success of your programs, so that we can together transform hope into health for millions of people around the world.

Blue Sky BioServices, founded in 2003 to serve the Boston area life sciences research hub, is the leading Contract Research Organization (CRO) providing R&D based Gene through Screen services for biotech and pharma companies from startups to established leaders in the field. Our customers enhance the quality and speed of their research by partnering with Blue Sky to receive world class services including; gene synthesis and bulk plasmid preparations, antibody cloning, scale-up production of recombinant proteins in multiple cell lines including mammalian, insect, bacterial and yeast, as well as antibody/protein purification and robust, rapid assay services such as cytotoxicity and qPCR, MSD. Our Assay team can support many commercially available screening technology in 96 and 384-well formats (fluorescent, colorimetric, etc.). Ultimately, we want to run YOUR assay, YOUR way. We will build out additional capabilities and capacity to support your screening workflow.

Blue Sky differentiates itself with its team of experienced scientists, leading edge process technology, and state-of-the-art laboratory facilities. Our commitment to scientific expertise and value has transformed the company into a center of excellence with unmatched quality and turnaround times.

We are motivated by ensuring our customers have an excellent experience working with Blue Sky. We do that by delivering projects on time, with high quality, at competitive prices, led by our team of highly skilled, energetic and collaborative scientists.

Blueclinical provides all the critical conditions necessary for the success of your research project. Blueclinical operates in three different areas:

• Blueclinical Phase I
Blueclinical Phase I conducts phase I studies in healthy subjects and early proof-of-concept studies in selected patient populations.

• Blueclinical R&D
Blueclinical R&D's mission is to fuel translation research by supporting Portuguese institutions and businesses, especially start-ups, in the development of their R&D projects with a view to the subsequent marketing.

• Blueclinical Clinical Research Partnership
Blueclinical CRP is a network of hospitals and primary care centers that serve approximately half (5 million people) of the Portuguese population. The full network operates under a common quality management system to deliver excellence in clinical research.
Blueclinical CRP is your right partner for your clinical trials or observational studies!
Blueclinical CRP is your right clinical partner for your Horizon 2020 project!

ChemDiv, a fully Integrated Target-to-Market Contract Research Organization (CRO) headquartered in San Diego, CA USA.
ChemDiv provides integrated drug discovery and early clinical development deliverables by extracting added value from potential therapeutic candidates via rapid, streamlined outcomes and effective use of capital.

- 25 years experience and 2500 customers worldwide
- Premium R&D CRO based in USA with global reach
- Seasoned project managers
- Extensive Academic partnerships
- Flexible business models
- Competitive pricing options
- Industry's largest ever-greening stock compound inventory
- Ongoing investments in novel proprietary chemistry and discovery platforms

One of the oldest CROs in the industry, ChemDiv provides Integrated Discovery outSource™ solutions that cover the complete range of disciplines needed to bring new drugs for treatment of CNS, oncology, inflammation, metabolic and infectious diseases from target to candidate and through clinical Proof of Concept to the market. ChemDiv champions collaborative development models with co-investors to rescue under-exploited R&D assets for pharmaceutical and biotech partners.